Review

. 2022 Apr;17(2):199-207.

doi: 10.1159/000516376. Epub 2021 Jul 19.

Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer

Kerstin Rhiem¹, Bernd Auber², Susanne Briest³, Nicola Dikow⁴, Nina Ditsch⁵, Neda Dragicevic⁶, Sabine Grill⁷, Eric Hahnen¹, Judit Horvath⁸, Bernadette Jaeger⁹, Karin Kast¹, Marion Kiechle⁷, Elena Leinert¹⁰, Susanne Morlot², Michael Püsken¹¹, Dieter Schäfer¹², Sarah Schott¹³, Christopher Schroeder¹⁴, Ulrike Siebers-Renelt⁸, Christine Solbach¹⁵, Nana Weber-Lassalle¹, Isabell Witzel¹⁶, Christine Zeder-Göß⁵, Rita K Schmutzler¹

Affiliations

¹ Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
² Department of Human Genetics, Hannover Medical School, Hannover, Germany.
³ Department of Obstetrics and Gynaecology, University Hospital of Leipzig, Leipzig, Germany.
⁴ Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
⁵ Department of Gynecology and Obstetrics, University Hospital of Augsburg, Augsburg, Germany.
⁶ Institute of Human Genetics, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
⁷ Department of Gynecology and Obstetrics, University Hospital Klinikum Rechts der Isar, Technical University Munich (TUM), Munich, Germany.
⁸ Institute for Human Genetics, University Hospital Münster, Münster, Germany.
⁹ Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
¹⁰ Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
¹¹ Department of Radiology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
¹² Institute for Human Genetics, University of Frankfurt, Frankfurt, Germany.
¹³ Department of Obstetrics and Gynaecology, University of Heidelberg, Heidelberg, Germany.
¹⁴ Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.
¹⁵ Department of Gynecology and Obstetrics, University Hospital Frankfurt, Frankfurt, Germany.
¹⁶ Department of Obstetrics and Gynaecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

PMID: 35702495
PMCID: PMC9149395
DOI: 10.1159/000516376

Review

Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer

Kerstin Rhiem et al. Breast Care (Basel). 2022 Apr.

. 2022 Apr;17(2):199-207.

doi: 10.1159/000516376. Epub 2021 Jul 19.

Authors

Affiliations

¹ Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
² Department of Human Genetics, Hannover Medical School, Hannover, Germany.
³ Department of Obstetrics and Gynaecology, University Hospital of Leipzig, Leipzig, Germany.
⁴ Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
⁵ Department of Gynecology and Obstetrics, University Hospital of Augsburg, Augsburg, Germany.
⁶ Institute of Human Genetics, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
⁷ Department of Gynecology and Obstetrics, University Hospital Klinikum Rechts der Isar, Technical University Munich (TUM), Munich, Germany.
⁸ Institute for Human Genetics, University Hospital Münster, Münster, Germany.
⁹ Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
¹⁰ Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
¹¹ Department of Radiology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
¹² Institute for Human Genetics, University of Frankfurt, Frankfurt, Germany.
¹³ Department of Obstetrics and Gynaecology, University of Heidelberg, Heidelberg, Germany.
¹⁴ Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.
¹⁵ Department of Gynecology and Obstetrics, University Hospital Frankfurt, Frankfurt, Germany.
¹⁶ Department of Obstetrics and Gynaecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

PMID: 35702495
PMCID: PMC9149395
DOI: 10.1159/000516376

Abstract

Background: The German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC) has established a multigene panel (TruRisk®) for the analysis of risk genes for familial breast and ovarian cancer.

Summary: An interdisciplinary team of experts from the GC-HBOC has evaluated the available data on risk modification in the presence of pathogenic mutations in these genes based on a structured literature search and through a formal consensus process.

Key messages: The goal of this work is to better assess individual disease risk and, on this basis, to derive clinical recommendations for patient counseling and care at the centers of the GC-HBOC from the initial consultation prior to genetic testing to the use of individual risk-adapted preventive/therapeutic measures.

Keywords: BRCA1; BRCA2; Consensus; Hereditary breast cancer; Hereditary ovarian cancer; Panel testing.

PubMed Disclaimer

Conflict of interest statement

Christopher Schroeder reports research support from Illumina and Bristol Myers Squibb and institutional research support from Novartis.

Cited by

Hereditary Breast and Ovarian Cancer Service in Sparsely Populated Western Pomerania.
Felbor U, Bülow R, Schmutzler RK, Rath M. Felbor U, et al. Healthcare (Basel). 2022 Oct 13;10(10):2021. doi: 10.3390/healthcare10102021. Healthcare (Basel). 2022. PMID: 36292468 Free PMC article.
Primary Prevention and Early Detection of Hereditary Breast Cancer.
Speiser D, Bick U. Speiser D, et al. Breast Care (Basel). 2023 Dec;18(6):448-454. doi: 10.1159/000533391. Epub 2023 Aug 14. Breast Care (Basel). 2023. PMID: 38125920 Free PMC article. Review.
Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores.
Padrik P, Tõnisson N, Hovda T, Sahlberg KK, Hovig E, Costa L, Nogueira da Costa G, Feldman I, Sampaio F, Pajusalu S, Ojamaa K, Kallak K, Tihamäe AT, Roht L, Kahre T, Lepland A, Sõber S, Kruuv-Käo K, Tamm M, Varghese J, Evans DG; AnteNOR and BRIGHT Research Consortia. Padrik P, et al. Cancers (Basel). 2025 Mar 21;17(7):1056. doi: 10.3390/cancers17071056. Cancers (Basel). 2025. PMID: 40227593 Free PMC article. Review.
Clinical Impact of Polygenic Risk Score for Breast Cancer Risk Prediction in 382 Individuals with Hereditary Breast and Ovarian Cancer Syndrome.
Stiller S, Drukewitz S, Lehmann K, Hentschel J, Strehlow V. Stiller S, et al. Cancers (Basel). 2023 Aug 2;15(15):3938. doi: 10.3390/cancers15153938. Cancers (Basel). 2023. PMID: 37568754 Free PMC article.
BRCA1/2 potential founder variants in the Jordanian population: an opportunity for a customized screening panel.
Ahmad O, Sutter C, Hirsch S, Pfister SM, Schaaf CP. Ahmad O, et al. Hered Cancer Clin Pract. 2023 Jul 3;21(1):11. doi: 10.1186/s13053-023-00256-2. Hered Cancer Clin Pract. 2023. PMID: 37400873 Free PMC article. Review.

See all "Cited by" articles

References

1. Waha A, et al. Konsensusempfehlung des Deutschen Konsortiums Familiärer Brust- und Eierstockkrebs zum Umgang mit Ergebnissen der Multigenanalyse. Geburtsh Frauenheilk. 2017;77:733–9.
1. Weber-Lassalle N, Hauke J, Ramser J, et al. BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer. Breast Cancer Res. 2018 Jan 24;20((1)):7. - PMC - PubMed
1. Weber-Lassalle N, Borde J, Weber-Lassalle K, et al. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer. Breast Cancer Res. 2019 Apr 29;21((1)):55. - PMC - PubMed
1. Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA. 2017;317((23)):2402–16. - PubMed
1. Engel C, Fischer C, Zachariae S, et al. Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance. Int J Cancer. 2020;146((4)):999–1009. - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer

Affiliations

Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Miscellaneous

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

Related information

LinkOut - more resources

Full Text Sources

Miscellaneous